Has Medical Properties Trust Bottomed Out? The Case for a Comeback
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on hospitals and other medical facilities. The company has been through an extremely trying couple of years, resulting in both dividend cuts and deteriorating share prices.
Now, however, things seem to finally be improving at Medical Properties Trust. Is MPW a buy as the business turns itself around, » Read more about: Has Medical Properties Trust Bottomed Out? The Case for a Comeback »
Read More
Market Commentary: Time To Buy This 9.12% Yield Stock?
It’s rare to find a stock offering a 9%+ yield that doesn’t have some murkiness under the hood, but is Medical Properties Trust (NYSE: MPW) that diamond in the rough?
We investigate whether this REIT that specializes in leasing healthcare facilities, a segment that has been traditionally regarded as recession-resistant, is worthy of a portfolio spot now.
» Read more about: Market Commentary: Time To Buy This 9.12% Yield Stock? »
Read More
Market Commentary: 1 Monthly Income Play You Don’t Want To Miss
If getting paid passively monthly sounds like something you’ve been looking for, Realty Income might be just the stock you’ve been looking for. From a single store 54 years ago, Realty Income is now a true behemoth that rewards investors seeking monthly income.
Read More
Alert: 1 Warren Buffett Stock To Buy Before Takeoff
Investment Alert: Buy Coca Cola (KO) Under $59/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
A glance at Berkshire’s portfolio will reveal Coca-Cola as one of its heavyweight investments,
» Read more about: Alert: 1 Warren Buffett Stock To Buy Before Takeoff »
Read More
This AI-Powered Sports Stock That Just Scored Big, Is It a Buy?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock to watch after soaring post earnings despite announcing mixed results for earnings versus revenue for Q4 of 2024.
The company surpassed consensus EPS estimates just once in the past four quarters but revenues have steadily increased and eclipsed consensus expectations.
» Read more about: This AI-Powered Sports Stock That Just Scored Big, Is It a Buy? »
Read MoreThe Burst
120,000 Reasons to Buy This Wide Moat Stock
Toast (NYSE:TOST) is a cloud technology provider that specializes in restaurant point-of-sale systems. The company’s software allows restaurants to process sales, track and manage inventories and even manage payroll and HR functions. To use these tools, restaurants purchase Toast’s POS, giving the company an effective competitive moat in every restaurant that decides to use it.
» Read more about: 120,000 Reasons to Buy This Wide Moat Stock »
Read MoreThe Spotlight
Spotlight: 1 Gene Editing Stock Set To Skyrocket
Cathie Wood has been investing heavily in Verve Therapeutics (VERV), a company developing therapies for cardiovascular diseases. So what’s all the fuss about? We took a deeper dive to find out.
Read MoreThe Daily
Dow Stalls as Market Struggles for Direction
Yields on Treasuries fell as investors continued to seek safe-haven assets as the risk of another U.S. government shutdown grows and investors await a Federal Reserve decision on Wednesday.
Gold has broken above the $5,000-an-ounce barrier as Senate Democrats resist supporting a funding bill for the Department of Homeland Security after another fatal shooting in Minneapolis,
» Read more about: Dow Stalls as Market Struggles for Direction »